Rahul A. Sheth

Rahul A. Sheth is an Associate Professor at The University of Texas MD Anderson Cancer Center, specializing in surgical oncology, cancer imaging, and immunotherapy. His research focuses on precision interventional oncology, particularly three-dimensional margin assessment for percutaneous thermal ablation of liver and lung tumors, and the integration of novel immunotherapeutic combinations, including NLRP3 agonists and sitravatinib with checkpoint inhibitors, for advanced solid tumors. He also investigates diagnostic challenges in cancer-associated pulmonary hypertension and SMARCB1-deficient renal medullary carcinoma. His recent work includes a randomized phase 2 trial (COVER-ALL) published in The Lancet, alongside contributions to Nature Communications and the Journal of Clinical Oncology.